ASP Isotopes Inc. ASPI
Options history
Table
| Date | IV |
|---|---|
| 119.38% | |
| 128.93% | |
| 127.83% | |
| 428.00% | |
| 104.43% | |
| 116.47% | |
| 111.56% | |
| 135.87% | |
| 88.24% | |
| 87.94% | |
| 89.94% | |
| 119.11% | |
| 88.63% | |
| 86.65% | |
| 97.72% | |
| 89.66% | |
| 96.17% | |
| 101.43% | |
| 86.55% | |
| 94.87% | |
| 120.40% | |
| 133.28% | |
| 137.44% |
Company coverage
Moat
WideProprietary Aerodynamic Separation Process (ASP) maintained as closely guarded trade secret with only 9 authorized individuals permitted access — strategically superior to patents (no public disclosure). 18+ years and tens of millions in R&D investm…
Physical assets
StrongThree commercial enrichment facilities in Pretoria, South Africa — genuinely productive, generating revenue from commercial isotope production (Silicon-28 shipped at 99.995% enrichment). Isotope separation plants are difficult to replicate due to te…
Software / hardware
Growth. Trade-secret enrichment process expands from Silicon-28 (quantum computing substrates) to uranium and lithium isotopes, creating a multi-commodity enrichment platform with near-monopoly pricing. Primary assets. 3 Pretoria enrichment faciliti…
- manual · sw-hw
Growth. Trade-secret enrichment process expands from Silicon-28 (quantum computing substrates) to uranium and lithium isotopes, creating a multi-commodity enrichment platform with near-monopoly pricing. Primary assets. 3 Pretoria…
- manual · physical-assets
Three commercial enrichment facilities in Pretoria, South Africa — genuinely productive, generating revenue from commercial isotope production (Silicon-28 shipped at 99.995% enrichment). Isotope separation plants are difficult to…
- manual · moat
Proprietary Aerodynamic Separation Process (ASP) maintained as closely guarded trade secret with only 9 authorized individuals permitted access — strategically superior to patents (no public disclosure). 18+ years and tens of mil…
| Action | Type | Relative size |
|---|---|---|
| SELL | Equity | +100% |
| BUY | CALL option | +1% |
| SELL | Equity | +7% |
| SELL | CALL option | +4% |
| SELL | Equity | +53% |
| SELL | CALL option | +2% |
| BUY | Equity | +47% |
| BUY | CALL option | +11% |
| BUY | Equity | +9% |
| SELL | CALL option | +5% |
| BUY | CALL option | +5% |
| BUY | Equity | +9% |
| BUY | Equity | +2% |
| BUY | Equity | +0% |
| BUY | CALL option | +12% |
| SELL | CALL option | +8% |
| BUY | Equity | +0% |
| SELL | CALL option | +3% |
| SELL | CALL option | +5% |
| BUY | CALL option | +1% |
| BUY | Equity | +2% |
| SELL | CALL option | +2% |
| SELL | CALL option | +2% |
| BUY | PUT option | +6% |
Notes
Full portfolio moat / asset analysis
Proprietary Aerodynamic Separation Process (ASP) maintained as closely guarded trade secret with only 9 authorized individuals permitted access — strategically superior to patents (no public disclosure). 18+ years and tens of millions in R&D investment. Regulatory barriers are substantial: uranium enrichment/isotope separation requires national security app…
Full portfolio moat / asset analysis
Three commercial enrichment facilities in Pretoria, South Africa — genuinely productive, generating revenue from commercial isotope production (Silicon-28 shipped at 99.995% enrichment). Isotope separation plants are difficult to replicate due to technical complexity and regulatory constraints. Additional planned facilities in the UK via Quantum Leap Energy.